Introduction: Prostate cancer is the leading cancer in men worldwide. It is also the second leading cause of cancer death in men. The incidence of prostate cancer increases with age, and it is more common in African American men than in Caucasian men
Prostate cancer screenings are the most efficient technique to detect the disease early. If your cancer risk is average, your first prostate screening will most likely be at the age of 55. If you have a family history of the disease or are Black, your healthcare professional may begin testing sooner. Screening is usually ended at the age of 70, however, it may be prolonged in some cases.
Prostate cancer screening tests include:
1. Digital rectal exam: Your provider feels the prostate gland, which sits in front of the rectum, using a gloved, lubricated finger inserted into the rectum. Bumps or hard spots might be signs of malignancy.
2. PSA blood test: The prostate gland produces a protein known as protein-specific antigen (PSA) (PSA). PSA levels that are too high might be a sign of malignancy. If you have BPH or prostatitis, your levels will also rise.
3. Biopsy: The only definite way to identify prostate cancer is to take a needle biopsy and look for cancer cells in the tissue. Magnetic resonance imaging (MRI) technology offers comprehensive pictures of the prostate during an MRI-guided prostate biopsy.
Treatment: surgery, radiation therapy, hormone therapy, or medication.
Prognosis: The prognosis is excellent if the tumour is found early. The more advanced it is, the less likely it will be cured.
The prostate, a tiny walnut-shaped gland that is part of a man’s reproductive system, develops prostate cancer. Prostate cancer affects one out of every nine males in the United States.
A portion of the male reproductive system is the prostate gland. During ejaculation, the gland produces fluid that combines with semen. This fluid protects and maintains the health of sperm in preparation for conception and pregnancy.
The prostate gland is located in front of the rectum, beneath a man’s bladder. The urethra goes through the prostate gland’s core. This tube transports urine and sperm from the penis to the outside of the body. Behind the prostate gland are the seminal vesicles that produce sperm
Men over the age of 55 are at a higher risk of developing the condition. As you become older, your chances of acquiring prostate cancer grow. In fact, males over the age of 65 account for 60% of prostate cancer cases. • Ethnicity is another risk factor (black men have the highest risk).
• Prostate cancer in the family.
• Obesity.
• Smoking.
Adenocarcinomas are the most common kind of prostate cancer (malignant tumors). This form of cancer begins in the cells that produce secretions in glands. Other cancers can occur in the prostate, although they are uncommon.
– Small cell carcinomas are one type of cancer.
-Transitional cell carcinomas are a kind of transitional cell carcinoma.
-Tumors of the neuroendocrine system.
-Sarcomas.
Experts are baffled as to why some cells in the prostate gland get cancerous (malignant). Genetics appears to be a factor. • If your father, brother, or son has prostate cancer, you’re two to three times more likely to have the condition.
• A small fraction of prostate cancers are caused by inherited mutated (changed) breast cancer genes (BRCA1 and BRCA2) and other gene changes.
Prostate cancer in its early stages seldom causes symptoms. As the condition advances, several issues may arise:
• Urination needs are frequent and occasionally urgent, especially at night.
• A sluggish pee flow or a flow that comes and goes.
• Urination that hurts (dysuria).
• Incontinence of the feces (bowel).
• Erectile dysfunction and painful ejaculation (ED).
• Blood in the sperm or urine (hematospermia).
• Pain in the lower back, hips, and chest.
• Numbness in the legs or feet.
Not all prostate growths are malignant, and not all prostate issues are indicative of cancer. Other illnesses that generate symptoms that are similar to prostate cancer include:
BPH (benign prostatic hyperplasia) is a kind of benign prostatic hyperplasia (BPH). Almost every guy will acquire benign prostatic hyperplasia at some time in his life (BPH). This disorder causes the prostate gland to expand, but it does not raise the risk of cancer. The urethra is squeezed by the enlarged gland, which prevents the passage of sperm and urine. Medications and, in certain cases, surgery can be beneficial.
• Prostatitis: Prostatitis, or inflammation and swelling of the prostate gland, is more common in men under 50. Bacterial infections are frequently to blame. Antibiotics and other drugs are used as treatments.
Prostate cancer strikes the majority of men as they get older for no apparent cause. There is no way to avoid it. If you have specific prostate cancer risk factors, however, doing the following activities can help you reduce your risk and diagnose the disease early:
• Have your prostate tested on a regular basis.
• Keep a healthy weight.
• Exercise on a regular basis.
• Eat a well-balanced diet.
• Give up smoking.
References:
- Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. The Lancet. 2017 Jan;
- Berney DM. The case for modifying the Gleason grading system. BJU Int. 2007;100(4):725–726.
- Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, et al. Complications After Systematic, Random, and Image-guided Prostate Biopsy. Eur Urol. 2017 Mar;71(3):353–65.
- Bostwick DG, Cheng L. Precursors of prostate cancer: Precursors of prostate cancer. Histopathology. 2012 Jan;60(1):4–27.
- Bourke L, Smith D, Steed L, Hooper R, Carter A, Catto J, et al. Exercise for Men with Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. 2016 Apr;69(4):693–703.
- Buskirk SJ, Pinkstaff DM, Petrou SP, Wehle MJ, Broderick GA, Young PR, et al. Acute urinary retention after transperineal template-guided prostate biopsy. Int J Radiat Oncol. 2004 Aug;59(5):1360–6.
- Cancer Research UK. Prostate cancer incidence statistics: by age (2013-2015) [Internet]. 2018. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence#heading-One
- Cancer Research UK. Prostate cancer incidence statistics: Lifetime risk of prostate cancer (2012) [Internet]. 2015 [cited 2018 Apr 19]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence#collapseFive
- Cao Y, Ma J. Body Mass Index, Prostate Cancer-Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis. Cancer Prev Res (Phila Pa). 2011 Jan 13;4(4):486–501.
- Chen Y-C, Page JH, Chen R, Giovannucci E. Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era. The Prostate. 2008 Oct 1;68(14):1582–91.
- Clouston D, Bolton D. In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 2: intraductal carcinoma and ductal adenocarcinoma of prostate. BJU Int. 2012 Dec;110 Suppl 4:22–4.
- Davies NJ, Batehup L, Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer. 2011 Nov 8;105:S52–73.
